SG11201401570YA - Pharmaceutical compositions of resveratrol - Google Patents

Pharmaceutical compositions of resveratrol

Info

Publication number
SG11201401570YA
SG11201401570YA SG11201401570YA SG11201401570YA SG11201401570YA SG 11201401570Y A SG11201401570Y A SG 11201401570YA SG 11201401570Y A SG11201401570Y A SG 11201401570YA SG 11201401570Y A SG11201401570Y A SG 11201401570YA SG 11201401570Y A SG11201401570Y A SG 11201401570YA
Authority
SG
Singapore
Prior art keywords
resveratrol
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Application number
SG11201401570YA
Inventor
Ross Stewart Grant
Keith Lindbeck
Original Assignee
Nad Life Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2011904326A external-priority patent/AU2011904326A0/en
Application filed by Nad Life Pty Ltd filed Critical Nad Life Pty Ltd
Publication of SG11201401570YA publication Critical patent/SG11201401570YA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/385Concentrates of non-alcoholic beverages
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05Phenols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A61K9/0058Chewing gums
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Inorganic Chemistry (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
SG11201401570YA 2011-10-19 2012-10-17 Pharmaceutical compositions of resveratrol SG11201401570YA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2011904326A AU2011904326A0 (en) 2011-10-19 Pharmaceutical Formulations of Resveratrol and Methods of Use Thereof For Treating Cell Disorders
PCT/AU2012/001253 WO2013056298A1 (en) 2011-10-19 2012-10-17 Pharmaceutical compositions of resveratrol

Publications (1)

Publication Number Publication Date
SG11201401570YA true SG11201401570YA (en) 2014-05-29

Family

ID=48140220

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201401570YA SG11201401570YA (en) 2011-10-19 2012-10-17 Pharmaceutical compositions of resveratrol

Country Status (8)

Country Link
US (1) US20140303260A1 (en)
EP (1) EP2768489A4 (en)
JP (1) JP2014530823A (en)
KR (1) KR20140108633A (en)
AU (1) AU2012325668A1 (en)
CA (1) CA2852968A1 (en)
SG (1) SG11201401570YA (en)
WO (1) WO2013056298A1 (en)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60146834A (en) * 1983-12-29 1985-08-02 Kitasato Inst:The Production of antibody for inhibiting periodontitis and noncarious composition containing said antibody
US4824680A (en) * 1988-05-19 1989-04-25 Wm. Wrigley, Jr. Company Non-staling gum composition with improved wrappability
AU5565696A (en) * 1995-04-24 1996-11-18 Wm. Wrigley Jr. Company Method for manufacturing chewing gum
WO2000038620A2 (en) * 1998-12-24 2000-07-06 1333366 Ontario Inc. A composition useful to treat periodontal disease
PE20010540A1 (en) * 1999-07-30 2001-05-15 Procter & Gamble COMPOSITION OF STYLBENE PHYTOALEXINS USEFUL FOR PROPHYLAXIS AND TREATMENT OF SYMPTOMS ASSOCIATED WITH COLD AND INFLUENZA-SIMILAR DISEASES
US20040013752A1 (en) * 2002-07-05 2004-01-22 Wolfson Philip E. Buccal and sublingual mucosally absorbed herbal compositions for relieving nicotine withdrawal symptoms and craving for nicotine and nicotine containing substances
CN101170913A (en) * 2005-04-29 2008-04-30 Wm.雷格利Jr.公司 Shaped chewing gum products and methods of making same
WO2009089334A1 (en) * 2008-01-08 2009-07-16 David Rubin Method and compositions for preserving wine
WO2009108999A1 (en) * 2008-03-03 2009-09-11 Ross Stewart Grant Pharmaceutical formulations of resveratrol and methods of use thereof for treating cell disorders
US9125858B2 (en) * 2009-11-30 2015-09-08 Wilmore Labs L.L.C. Compositions and methods relating to resveratrol

Also Published As

Publication number Publication date
EP2768489A1 (en) 2014-08-27
US20140303260A1 (en) 2014-10-09
JP2014530823A (en) 2014-11-20
CA2852968A1 (en) 2013-04-25
WO2013056298A1 (en) 2013-04-25
KR20140108633A (en) 2014-09-12
AU2012325668A1 (en) 2014-05-08
EP2768489A4 (en) 2015-01-21

Similar Documents

Publication Publication Date Title
HK1210706A1 (en) Inhalable pharmaceutical compositions
AP3864A (en) Pharmaceutical composition
IL230010B (en) Inhalable pharmaceutical compositions
GB201113662D0 (en) Pharmaceutical compositions
ZA201308208B (en) Pharmaceutical compositions
HK1199824A1 (en) Pharmaceutical compositions
GB201118232D0 (en) Pharmaceutical composition
EP2731605A4 (en) Pharmaceutical compositions for rectal administration
EP2702989A4 (en) Stable pharmaceutical composition
IL237139A0 (en) Pharmaceutical compositions of memantine
HRP20180567T1 (en) Pharmaceutical composition of omeprazole
HK1189158A1 (en) Pharmaceutical composition
EP2769718A4 (en) Medicinal composition
GB201118181D0 (en) Pharmaceutical compositions
ZA201402165B (en) Compositions of lopinavir
EP2727593A4 (en) Nicorandil-containing pharmaceutical composition
EP2711010A4 (en) Pharmaceutical composition
HUP1100444A2 (en) Pharmaceutical composition
ZA201308414B (en) Solid pharmaceutical composition
GB201100786D0 (en) Pharmaceutical compositions of immunosuppressants
EP2714715A4 (en) Pharmaceutical compositions
HUP1100445A2 (en) Pharmaceutical composition
SG11201401570YA (en) Pharmaceutical compositions of resveratrol
ZA201309537B (en) Pharmaceutical composition comprising fexofedine
GB201105224D0 (en) Novel pharmaceutical compositions